We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+0.8%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$796M
AUM Growth
-$185M
Cap. Flow
-$163M
Cap. Flow %
-20.42%
Top 10 Hldgs %
3.37%
Holding
1,987
New
622
Increased
338
Reduced
393
Closed
624

Top Sells

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$5.34M
2
MSFT icon
Microsoft
MSFT
+$5.22M
3
OPLN
Openlane
OPLN
+$4.6M
4
AAPL icon
Apple
AAPL
+$4.51M
5
HRI icon
Herc Holdings
HRI
+$4.09M

Sector Composition

Rank Sector Weight
1 Healthcare 16.45%
2 Industrials 15.7%
3 Technology 14.88%
4 Consumer Discretionary 11.13%
5 Financials 10.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GSK icon
776
GSK
GSK
$106B
$380K 0.05%
+6,899
New +$359K
SDGR icon
777
Schrodinger
SDGR
$1.36B
$380K 0.05%
+10,906
New +$498K
UTZ icon
778
Utz Brands
UTZ
$1.25B
$380K 0.05%
+23,852
New +$380K
BP icon
779
BP
BP
$107B
$379K 0.05%
+14,250
New +$395K
FMC icon
780
FMC
FMC
$1.33B
$379K 0.05%
3,449
+1,208
+54% +$121K
WTFC icon
781
Wintrust Financial
WTFC
$10.7B
$379K 0.05%
4,168
-1,824
-30% -$163K
SPTM icon
782
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$14B
$378K 0.05%
6,463
CBSH icon
783
Commerce Bancshares
CBSH
$8.5B
$377K 0.05%
6,667
-8,822
-57% -$496K
OLMA icon
784
Olema Pharmaceuticals
OLMA
$1.05B
$377K 0.05%
+40,227
New +$833K
SPNT icon
785
SiriusPoint
SPNT
$2.68B
$377K 0.05%
+46,404
New +$409K
BIO icon
786
Bio-Rad Laboratories Class A
BIO
$9.42B
$376K 0.05%
+498
New +$373K
HCSG icon
787
Healthcare Services Group
HCSG
$1.53B
$376K 0.05%
21,145
+4,130
+24% +$80.3K
SVC
788
Service Properties Trust
SVC
$1.07B
$376K 0.05%
8,551
+2,846
+50% +$145K
PNTG icon
789
Pennant Group
PNTG
$1.36B
$375K 0.05%
16,238
-8,571
-35% -$198K
SRI icon
790
Stoneridge
SRI
$213M
$375K 0.05%
18,997
+8,356
+79% +$177K
CEQP
791
DELISTED
Crestwood Equity Partners LP
CEQP
$373K 0.05%
+13,525
New +$377K
CUBE icon
792
CubeSmart
CUBE
$9.41B
$372K 0.05%
6,528
-31,728
-83% -$1.71M
TRIN icon
793
Trinity Capital Inc.
TRIN
$1.71B
$371K 0.05%
21,124
+2,494
+13% +$41.4K
URGN icon
794
UroGen Pharma
URGN
$2.29B
$371K 0.05%
39,064
+18,559
+91% +$262K
GEF icon
795
Greif
GEF
$5.04B
$370K 0.05%
+6,127
New +$397K
HEI icon
796
HEICO Corp
HEI
$51.4B
$370K 0.05%
2,566
-5,145
-67% -$725K
CFFN icon
797
Capitol Federal Financial
CFFN
$1.1B
$369K 0.05%
32,546
+21,881
+205% +$258K
WSBC icon
798
WesBanco
WSBC
$4B
$369K 0.05%
10,539
+1,428
+16% +$50.2K
MIRM icon
799
Mirum Pharmaceuticals
MIRM
$6.14B
$368K 0.05%
23,101
-16,607
-42% -$258K
TALO icon
800
Talos Energy
TALO
$2.4B
$368K 0.05%
37,549
-42,915
-53% -$489K

Similar funds

GSA Capital Partners's Q4 2021 Portfolio in Review

As of Q4 2021, GSA Capital Partners held 1,987 positions worth $796M, down 19% from $982M the previous quarter. Its ten largest holdings account for 3.4% of the portfolio.

GSA Capital Partners withdrew a net $163M in Q4 2021, closing 624 positions and reducing 393 holdings. Its most notable exit was Morgan Stanley, an estimated $5.34M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Industrials and Technology.

Against the trend, GSA Capital Partners opened a new position in Genius Sports worth $2.45M.

  • GSA Capital Partners's largest Q4 2021 buy was Genius Sports: 322,717 shares worth $2.45M.
  • GSA Capital Partners added most to State Street Consumer Staples Select Sector SPDR ETF in Q4 2021, an estimated $2.43M increase.
  • GSA Capital Partners's biggest Q4 2021 reduction was Microsoft, cutting an estimated $5.22M.
  • GSA Capital Partners fully exited Morgan Stanley in Q4 2021, selling an estimated $5.34M.
  • GSA Capital Partners's ten largest holdings make up 3.4% of its $796M portfolio in Q4 2021.
  • GSA Capital Partners opened 622 new positions and closed 624 in Q4 2021.
  • GSA Capital Partners's portfolio value fell 19% quarter-over-quarter to $796M.

Based on GSA Capital Partners's 13F filing for Q4 2021, filed 14 Feb 2022.